These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35078016)

  • 1. TAK1 accelerates transplant arteriosclerosis in rat aortic allografts by inducing autophagy in vascular smooth muscle cells.
    Zheng X; Yu Q; Shang D; Yin C; Xie D; Huang T; Du X; Wang W; Yan X; Zhang C; Li W; Song Z
    Atherosclerosis; 2022 Feb; 343():10-19. PubMed ID: 35078016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism.
    Yu Q; Li W; Xie D; Zheng X; Huang T; Xue P; Guo B; Gao Y; Zhang C; Sun P; Li M; Wang G; Cheng X; Zheng Q; Song Z
    EBioMedicine; 2018 Oct; 36():39-53. PubMed ID: 30241919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bves maintains vascular smooth muscle cell contractile phenotype and protects against transplant vasculopathy via Dusp1-dependent p38MAPK and ERK1/2 signaling.
    Liu JX; Huang T; Xie D; Yu Q
    Atherosclerosis; 2022 Sep; 357():20-32. PubMed ID: 36037759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
    Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
    Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated anti-sense extracellular signal-regulated kinase 2 gene therapy inhibits activation of vascular smooth muscle cells and angiogenesis, and ameliorates transplant arteriosclerosis.
    Zhao B; Li X; Dai X; Gong N
    Transplant Proc; 2013 Mar; 45(2):639-42. PubMed ID: 23498803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
    Chen Q; Yang F; Guo M; Wen G; Zhang C; Luong le A; Zhu J; Xiao Q; Zhang L
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):75-86. PubMed ID: 26493107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desalted Salicornia europaea extract attenuated vascular neointima formation by inhibiting the MAPK pathway-mediated migration and proliferation in vascular smooth muscle cells.
    Won KJ; Lee KP; Baek S; Cui L; Kweon MH; Jung SH; Ryu YK; Hong JM; Cho EA; Shin HS; Kim B
    Biomed Pharmacother; 2017 Oct; 94():430-438. PubMed ID: 28778046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of
    Ouyang C; Li J; Zheng X; Mu J; Torres G; Wang Q; Zou MH; Xie Z
    Autophagy; 2021 Dec; 17(12):4305-4322. PubMed ID: 33985412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
    Feng S; Gao L; Zhang D; Tian X; Kong L; Shi H; Wu L; Huang Z; Du B; Liang C; Zhang Y; Yao R
    Int J Biol Sci; 2019; 15(12):2615-2626. PubMed ID: 31754334
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine-induced apoptosis inhibitor 1 (CIAPIN1) accelerates vascular remodelling via p53 and JAK2-STAT3 regulation in vascular smooth muscle cells.
    Han JH; Heo KS; Myung CS
    Br J Pharmacol; 2021 Nov; 178(22):4533-4551. PubMed ID: 34289085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-power laser irradiation inhibits PDGF-BB-induced migration and proliferation via apoptotic cell death in vascular smooth muscle cells.
    Baek S; Lee KP; Cui L; Ryu Y; Hong JM; Kim J; Jung SH; Bae YM; Won KJ; Kim B
    Lasers Med Sci; 2017 Dec; 32(9):2121-2127. PubMed ID: 28983687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
    Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
    Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of intimal hyperplasia in murine aortic allografts by the oral administration of the transforming growth factor-beta receptor I kinase inhibitor SD-208.
    Sun Y; Ye P; Wu J; Liu Z; Zhang A; Ren L; Cheng C; Huang X; Wang K; Deng P; Wu C; Yue Z; Xia J
    J Heart Lung Transplant; 2014 Jun; 33(6):654-61. PubMed ID: 24685405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense extracellular signal-regulated kinase-2 gene therapy inhibits platelet-derived growth factor-induced proliferation, migration and transforming growth factor-beta(1) expression in vascular smooth muscle cells and attenuates transplant vasculopathy.
    Chen XL; Chen ZS; Ding Z; Dong C; Guo H; Gong NQ
    Transpl Int; 2008 Jan; 21(1):30-8. PubMed ID: 17927678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
    Nurminskaya M; Beazley KE; Smith EP; Belkin AM
    J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of β-catenin dynamics.
    Zhong W; Oguljahan B; Xiao Y; Nelson J; Hernandez L; Garcia-Barrio M; Francis SC
    Cell Signal; 2014 Dec; 26(12):2765-72. PubMed ID: 25152363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.